Cardialen is one of the most promising medical startups to come out of St. Louis in recent years. It recently raised $3 million in venture capital, and it’s close to starting clinical trials for a device to treat atrial fibrillation, the most common type of irregular heartbeat. The device was invented by Igor Efimov, a Washington University professor of biomedical engineering, and the firm was nurtured by private and public investment groups here. From a St. Louis point of view, there’s only one thing wrong with this picture: Cardialen is now based in Minneapolis.
Image: The Gateway Arch is lit up in this view from the east taken on Nov. 22, 2001. Photo by Andrew Cutraro of the Post-Dispatch
To read the original article: Nicklaus: Lessons from a startup that got away : Business
